Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.28 -1.18%
EPS Growth %: -266.7%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -266.7%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $55.2 million versus the consensus estimate of $55.28 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
